XML 25 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statement of Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period Of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Distributions in Excess of Accumulated Earnings
Distributions in Excess of Accumulated Earnings
Cumulative Effect, Period Of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Issuance of common stock under:                
Cumulative effect upon adoption of ASU No. 2016-13 $ 6,403,504 $ (190) $ 7 $ 7,121,927 $ (887,619) $ (190) $ (13,888) $ 183,077
Balance at period beginning (in shares) at Dec. 31, 2019     66,092          
Balance at period beginning at Dec. 31, 2019 6,403,504 $ (190) $ 7 7,121,927 (887,619) $ (190) (13,888) 183,077
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 497,683       473,125     24,558
Cash flow hedge losses reclassified to earnings 3,282           3,171 111
Change in fair value of derivatives and amortization of swap settlements (6,119)           (5,911) (208)
Change in fair value of marketable debt securities, net (178)           (172) (6)
Issuance of common stock under:                
Stock option and restricted stock plans, net (in shares)     95          
Stock option and restricted stock plans, net 9,201     9,201        
Sale of common stock, net (228)     (228)        
Equity based compensation costs 9,294     8,956       338
Retirement of common stock, net (in shares)     (985)          
Retirement of common stock, net (222,990)     (222,990)        
Changes in the redemption value of redeemable noncontrolling interest 6,691     6,888       (197)
Changes in noncontrolling interest from acquisition 1,349             1,349
Distributions to noncontrolling interest (23,689)             (23,689)
Redemptions of noncontrolling interest (in shares)     8          
Redemptions of noncontrolling interest (2,971)     (2,123)       (848)
Common stock dividends (407,157)       (407,157)      
Balance at period end (in shares) at Sep. 30, 2020     65,210          
Balance at period end at Sep. 30, 2020 6,267,482   $ 7 6,921,631 (821,841)   (16,800) 184,485
Issuance of common stock under:                
Cumulative effect upon adoption of ASU No. 2016-13 6,352,881   $ 7 6,944,805 (760,028)   (18,710) 186,807
Balance at period beginning (in shares) at Jun. 30, 2020     65,331          
Balance at period beginning at Jun. 30, 2020 6,352,881   $ 7 6,944,805 (760,028)   (18,710) 186,807
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 78,842       73,661     5,181
Change in fair value of derivatives and amortization of swap settlements 1,884           1,821 63
Change in fair value of marketable debt securities, net 92           89 3
Issuance of common stock under:                
Sale of common stock, net (95)     (95)        
Equity based compensation costs 2,361     2,279       82
Retirement of common stock, net (in shares)     (121)          
Retirement of common stock, net (26,586)     (26,586)        
Changes in the redemption value of redeemable noncontrolling interest 2,522     2,346       176
Distributions to noncontrolling interest (7,677)             (7,677)
Redemptions of noncontrolling interest (1,268)     (1,118)       (150)
Common stock dividends (135,474)       (135,474)      
Balance at period end (in shares) at Sep. 30, 2020     65,210          
Balance at period end at Sep. 30, 2020 6,267,482   $ 7 6,921,631 (821,841)   (16,800) 184,485
Issuance of common stock under:                
Cumulative effect upon adoption of ASU No. 2016-13 6,267,482   7 6,921,631 (821,841)   (16,800) 184,485
Cumulative effect upon adoption of ASU No. 2016-13 6,183,192   $ 6 6,876,326 (861,193)   (14,729) 182,782
Balance at period beginning (in shares) at Dec. 31, 2020     64,999          
Balance at period beginning at Dec. 31, 2020 6,183,192   $ 6 6,876,326 (861,193)   (14,729) 182,782
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 371,566       351,680     19,886
Change in fair value of derivatives and amortization of swap settlements 5,607           5,417 190
Change in fair value of marketable debt securities, net 356           344 12
Issuance of common stock under:                
Stock option and restricted stock plans, net (in shares)     112          
Stock option and restricted stock plans, net 12,402   $ 1 12,401        
Sale of common stock, net (202)     (202)        
Equity based compensation costs 9,495     9,172       323
Retirement of common stock, net (in shares)     (40)          
Retirement of common stock, net (9,172)     (9,172)        
Changes in the redemption value of redeemable noncontrolling interest (4,922)     (5,499)       577
Contributions from noncontrolling interest 1,900             1,900
Distributions to noncontrolling interest (22,114)             (22,114)
Redemptions of noncontrolling interest (in shares)     10          
Redemptions of noncontrolling interest (8,407)     (7,518)       (889)
Common stock dividends (407,802)       (407,802)      
Balance at period end (in shares) at Sep. 30, 2021     65,081          
Balance at period end at Sep. 30, 2021 6,131,899   $ 7 6,875,508 (917,315)   (8,968) 182,667
Issuance of common stock under:                
Cumulative effect upon adoption of ASU No. 2016-13 6,136,703   $ 7 6,862,879 (899,663)   (9,768) 183,248
Balance at period beginning (in shares) at Jun. 30, 2021     65,004          
Balance at period beginning at Jun. 30, 2021 6,136,703   $ 7 6,862,879 (899,663)   (9,768) 183,248
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 125,002       118,390     6,612
Change in fair value of derivatives and amortization of swap settlements 728           704 24
Change in fair value of marketable debt securities, net 99           96 3
Issuance of common stock under:                
Stock option and restricted stock plans, net (in shares)     68          
Stock option and restricted stock plans, net 15,572     15,572        
Sale of common stock, net (118)     (118)        
Equity based compensation costs 1,628     1,573       55
Changes in the redemption value of redeemable noncontrolling interest 1,673     1,253       420
Distributions to noncontrolling interest (7,257)             (7,257)
Redemptions of noncontrolling interest (in shares)     9          
Redemptions of noncontrolling interest (6,089)     (5,651)       (438)
Common stock dividends (136,042)       (136,042)      
Balance at period end (in shares) at Sep. 30, 2021     65,081          
Balance at period end at Sep. 30, 2021 6,131,899   $ 7 6,875,508 (917,315)   (8,968) 182,667
Issuance of common stock under:                
Cumulative effect upon adoption of ASU No. 2016-13 $ 6,131,899   $ 7 $ 6,875,508 $ (917,315)   $ (8,968) $ 182,667